Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. Continuous glucose monitors are small, wearable devices that track ...

Tipster MysticLeaks suggested in a Telegram channel post that Google's upcoming Tensor G7 chipset, which is likely to power ...

DexCom posted better-than-expected Q1 2026 results, with revenue up 15% year-over-year on strong uptake of its G7 continuous glucose monitor and expanded coverage for type 2 diabetes patients not ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to invest in for the next 2 years. On April 30, DexCom reported Q1 ...

Compare Apple Watch, Garmin, Oura, Samsung, Withings, Huawei, and Evie Ring in the race to bring blood sugar data to ...

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

Tandem Diabetes Care (Nasdaq:TNDM) announced that it made its t:slim X2 insulin pump available with the Dexcom (Nasdaq:DXCM) ...

Dexcom () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smarter ...

Q1 2026 earnings call: 15% revenue growth, Prime coverage expansion, G7 15 Day rollout, and raised margin outlook.

April 30 () - Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street ...

(Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2026. First Quarter 2026 Fin ...

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – There's a quiet bidding war underway for AI diagnostics, and the price ...